This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson’s long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson’s long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. Cheryl Gerber, Johnson & Johnson via AP
Herb Scribner
By Herb Scribner

Dr. Anthony Fauci, one of the country’s top infectious disease experts, doesn’t want you to think the COVID-19 vaccine from Johnson & Johnson is less effective than others.

Fauci said in a new interview with the “Today” show that the news that Johnson & Johnson’s vaccine is safe is “nothing but good news.”

  • “When you have a company like Johnson & Johnson that has a very good track record with pharmaceuticals, to have them be in the mix with the other two is nothing but good news.”
Related
Johnson & Johnson’s COVID-19 vaccine is safe, FDA analysis says. Here’s what happen next

Fauci was asked about concerns over the J&J vaccine, which is 72% effective compared to Moderna’s vaccine, which is 95% effective.

  • Fauci said: “People should get vaccinated. ... Where a vaccine becomes available, take it.”
  • “This is a race between the virus and getting vaccines into people. The longer someone waits to get vaccinated, the better chance the virus has to get a variant or a mutation. So the sooner we get vaccine into the arms of individuals, whatever that vaccine is, once it gets approved by the FDA, if it’s available to you, get it.”

Context

On Wednesday, Johnson & Johnson’s single-dose COVID-19 vaccine was revealed to be safe and effective, according to a new analysis from the Food and Drug Administration, The Wall Street Journal reports.

Related
Johnson & Johnson has asked the FDA to approve its vaccine. Here’s why that’s historic
  • There were no deaths among those who received the vaccine, The Wall Street Journal reports.
  • The vaccine also ”demonstrated complete protection against COVID-related hospitalization and death, 28 days post-vaccination,” according to Johnson & Johnson.
View Comments

The new J&J vaccine could be approved for use “as soon as this weekend,” The Washington Post reports.

Join the Conversation
Looking for comments?
Find comments in their new home! Click the buttons at the top or within the article to view them — or use the button below for quick access.